| Number of Patients, Male | 6 |
| Number of Patients, Female | 3 |
| Stage |
III: 1 (11.1%) IV M1a–b: 4 (44.4%) IV M1c: 4 (44.4%) |
| Age | Median (range): 52 years (27–77) years |
| Number of prior systemic therapies | Median (range): 1 (0–2) |
| Performance Status: ECOG |
0 — 6 1 — 3 2 — 0 3 — 0 Unknown — 0 |
| Other |
Primary tumor site: Cutaneous 4 (44.4%) Mucosal 2 (22.2%) Unknown primary 3 (33.3%) BRAF mutation status: BRAF class 2: 2 (22.2%) BRAF class 3: 5 (55.5%) BRAF fusion: 2 (22.2%) |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.